MEGAN GIESKE: Open Payments
NPI 1124454269 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,918 in 266 payments from 23 companies in 2025. Trend: 2023 $3,692 · 2024 $4,332 · 2025 $6,918
Food & beverage: $6,882Education: $36
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 80 | $1,918 |
| Madrigal Pharmaceuticals | 18 | $861 |
| Medtronic, Inc. | 9 | $527 |
| Janssen Biotech, Inc. | 26 | $503 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $449 |
| Lilly USA, LLC | 19 | $445 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $414 |
| Ardelyx, Inc. | 10 | $288 |
| Aimmune Therapeutics, Inc. | 11 | $275 |
| Novo Nordisk Inc | 5 | $274 |
Products named: REZDIFFRA, SKYRIZI, TREMFYA, INTERSTIM, XIFAXAN, OMVOH, LINZESS, ENTYVIO.
Industry payments across OH — which companies pay providers there.
